Being Exclusive

The latest version of the US health bill includes a provision about generic biotech drugs. The version passed by the House Energy and Commerce Committee gives biotech drugs 12-year exclusivity period, reports the Wall Street Journal Health Blog. The chair of the committee, Henry Waxman, earlier this year called for a five-year period of exclusivity.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.